<DOC>
	<DOCNO>NCT00805441</DOCNO>
	<brief_summary>H8R-MC-HJAQ Phase 2 , parallel , double-blind , randomize study compare LY686017 placebo 12-week trial include Medical Management . This study outpatient study approximately 180 alcohol dependent subject enrol . Subjects randomize 1:1 fashion LY686017 placebo , receive daily dose twelve week .</brief_summary>
	<brief_title>A Study Treatment Alcohol Dependence .</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<criteria>Have Alcohol Dependence . Are men woman ambulatory outpatient 21 65 year age ( inclusive ) show evidence live noncustodial stable residence plan move next 5 month . Females childbearing potential ( surgically sterilize menopause ) must test negative pregnancy time enrollment base pregnancy test . They must agree use reliable method birth control study 2 month follow last dose study drug . Drink average 14 drink ( woman ) 21 drink ( men ) per week least 2 heavy drinking day per week . Endorse abstinence reduction drink interim goal toward abstinence . Are investigator site personnel directly affiliate study and/or immediate family . Are Lilly employee . Are currently enrol discontinue within last 30 day clinical trial . Have experience acute alcohol withdrawal syndrome within past 6 month currently study significant risk suffer acute alcohol withdrawal syndrome . Have history serious head injury , neoplasm hemorrhage , prior seizure ( history childhood febrile seizure ) , condition would place subject increase risk seizure . Are take take anticonvulsant medication seizure . Are diagnosed substance dependence substance abuse alcohol , cannabis , nicotine , caffeine within 12 month prior first visit . Are receive medication intensive behavioral psychological therapy deliver licensed certified alcohol treatment specialist alcohol dependence . Have sign symptom active illness within past 2 week first visit meet criterion diagnosis Major Depressive Disorder . In addition , meet criterion diagnosis comorbid Axis I disorder ( anxiety disorder , OCD , PTSD , panic disorder , dysthymia ) . Have positive urine drug screen nonprescribed substance abuse . Have serious medical illness include limited cardiovascular , hepatic , respiratory , hematological , endocrine , neurological disease , clinically significant laboratory abnormality . Ever electroconvulsive therapy ( ECT ) . Have abnormal thyroid stimulate hormone ( TSH ) concentration take thyroid supplement . Have history cirrhosis laboratory evidence hepatocellular injury . An abnormality serum Prothrombin time . Are unable make available duration study abide study procedure restriction .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Alcoholic</keyword>
</DOC>